Skip to main content
SpringerLink
Log in

ASO Author Reflections: When is the Best Time to Perform Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Recurrent Low-Grade Appendiceal Mucinous Neoplasm?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res. 1980;40:256–60.

    CAS  PubMed  Google Scholar 

  2. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei.” Am J Surg Pathol. 1995;19:1390–408.

    Article  CAS  Google Scholar 

  3. Baratti D, Kusamura S, Milione M, Bruno F, Guaglio M, Deraco M. Validation of the recent PSOGI pathological classification of pseudomyxoma peritonei in a single-center series of 265 patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25:404–13.

    Article  Google Scholar 

  4. Reiter S, Rog CJ, Alassas M, Ong E. Progression to pseudomyxoma peritonei in patients with low grade appendiceal mucinous neoplasms discovered at time of appendectomy. Am J Surg. 2021. https://doi.org/10.1016/j.amjsurg.2021.12.003.

    Article  PubMed  Google Scholar 

  5. Valenzuela CD, Mangieri CW, Garland-Kledzik M, et al. Timing of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for recurrent low-grade appendiceal mucinous neoplasms. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11440-4.

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Comprehensive Cancer Center, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA

    Cristian D. Valenzuela MD, Konstantinos I. Votanopoulos MD, PhD, Edward A. Levine MD & Perry Shen MD

Authors
  1. Cristian D. Valenzuela MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Konstantinos I. Votanopoulos MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Edward A. Levine MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Perry Shen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Perry Shen MD.

Ethics declarations

Disclosure

Cristian D. Valenzuela, Konstantinos I. Votanopoulos, Edward A. Levine, and Perry Shen declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Valenzuela, C.D., Votanopoulos, K.I., Levine, E.A. et al. ASO Author Reflections: When is the Best Time to Perform Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Recurrent Low-Grade Appendiceal Mucinous Neoplasm?. Ann Surg Oncol 29, 3432–3433 (2022). https://doi.org/10.1245/s10434-022-11515-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11515-2

Search

Navigation